insider buy from marketbeat.comKnight Therapeutics Inc. (
TSE:GUD -
Get Free Report) Director Samira Sakhia bought 20,000 shares of Knight Therapeutics stock in a transaction on Monday, November 11th. The shares were acquired at an average price of C$5.15 per share, for a total transaction of C$103,000.00.